EXCLUSIVE: Citron Research’s Andrew Left Is Short GameStop Again
Andrew Left shared with Benzinga that he once again bet against GameStop in May 2024 amidst a rally in the share price.
EXCLUSIVE: Andrew Left Disagrees With ‘Dumb Money’ GameStop Storyline: ‘The Story Still Goes Down As If The Short Sellers Were The Bad Guys’
A movie about the GameStop short squeeze of 2021 makes short sellers the bad guys. Citron Research founder Andrew Left disagrees with this notion.
EXCLUSIVE: Boxing Legend Claressa Shields On Paving The Way For Women’s Sports — Without Her Footwork, ‘Angel Reese And Caitlin Clark Would Still Be Having To Put In The Work’
Claressa Shields recalled putting in the work to help fight for equality in women's sports during an interview with Benzinga. How Shields may have helped Caitlin Clark years before her WNBA debut.
EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
Trading expert Anne-Marie Baiynd shared option trade ideas for Tesla on Benzinga's YouTube, discussing potential positive catalysts and bullish strategies.
EXCLUSIVE: Trinity Capital Invests $25M in Elevate K-12 to Support Expansion of Live Online Teaching
Trinity Capital Inc (NASDAQ: TRIN) commits $25 million to Elevate K-12 for growth initiatives. This will help solve teacher vacancies and expand services.
EXCLUSIVE: REE Partners with Penske to Launch P7-C EV Trucks, Enhancing Fleet Electrification Options
REE Automotive partners with Penske Truck Leasing to offer Powered by REE EVs to customers, adding momentum to their $50 million order book.
EXCLUSIVE: Zapata AI Partners With India-Based Tech Mahindra To Transform Network And Customer Operations
Zapata Computing partners with Tech Mahindra to revolutionize CSP solutions. Leveraging Zapata AI's quantum-based Generative AI, expect enhanced operational efficiency, proactive maintenance, and personalized customer interactions.
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
The weekly Stock Whisper Index highlights five stocks seeing increased interest from Benzinga readers.
EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
Alzamend Neuro seals $500,000 Series A Convertible Preferred Stock deal with an investor. Plans to raise up to $25 million for clinical trials and working capital.